1998
DOI: 10.1097/00005537-199810000-00003
|View full text |Cite
|
Sign up to set email alerts
|

Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients

Abstract: Botulinum toxin A injection of the laryngeal hyperfunctional muscles has been found over the past 12 years to be the treatment of choice to control the dystonic symptoms in most patients with spasmodic dysphonia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
92
2
8

Year Published

2001
2001
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 321 publications
(107 citation statements)
references
References 31 publications
5
92
2
8
Order By: Relevance
“…The dosage may vary from 1 MU to 30 MU depending on the patient's response to the treatment, the level of side effects, and the technique used. Blitzer et al (36) recommend initiating the treatment with an average of 1 MU and then adjusting the dose according to the patient's response. According to Blitzer et al (36), 90% of patients with adductor SD benefit from the botulinum toxin treatment and have a symptom-free period of 15 weeks on average.…”
Section: Treatmentmentioning
confidence: 99%
See 3 more Smart Citations
“…The dosage may vary from 1 MU to 30 MU depending on the patient's response to the treatment, the level of side effects, and the technique used. Blitzer et al (36) recommend initiating the treatment with an average of 1 MU and then adjusting the dose according to the patient's response. According to Blitzer et al (36), 90% of patients with adductor SD benefit from the botulinum toxin treatment and have a symptom-free period of 15 weeks on average.…”
Section: Treatmentmentioning
confidence: 99%
“…Abductor SD: In these patients, botulinum toxin injections have been administered into the PCA muscle since 1989 (36). As a treatment protocol, Blitzer et al (36) recommend that, first of all, a more active PCA should be determined through EMG and a 3.75 MU Botulinum toxin should be injected into the muscle; then, botulinum toxin at lower doses should be injected into the contralateral PCA muscle of patients with ongoing symptoms during the follow-ups.…”
Section: Treatmentmentioning
confidence: 99%
See 2 more Smart Citations
“…In addition to medications, lingual dystonia has been reported to occur secondary to head injury, electrical injury, varicella infection or part of a neurodegenerative disease. [39][40][41][42] Action induced lingual dystonia can be a striking and early finding in chorea-acanthocytosis. It is also a characteristic of pantothenate kinase associated neurodegeneration (PKAN), Lesch-Nyhan syndrome and Wilsons disease.…”
Section: Lingual Dystoniamentioning
confidence: 99%